Jeronimo Célia, Archambault Denis
Laboratory of Molecular Virology and Immunology, Department of Biological Sciences, University of Québec at Montréal, Succursale Centre-Ville, Montréal, Québec, Canada H3C 3P8.
Clin Diagn Lab Immunol. 2002 May;9(3):698-703. doi: 10.1128/cdli.9.3.698-703.2002.
Equine arteritis virus (EAV), an enveloped positive-stranded RNA virus, is the prototype of the arterivirus group. In a previous paper (A. Kheyar, S. Martin, G. St.-Laurent, P. J. Timoney, W. H. McCollum, and D. Archambault, Clin. Diagn. Lab. Immunol. 4:648-652, 1997), we have shown that the unglycosylated membrane (M) protein, which is composed of 162 amino acids (aa), is a major target of equine antibody to EAV. In order to determine the antigenic regions of the M protein, the cDNA encoding the M protein of EAV was inserted into the procaryotic expression vector pGEX-4T-1 to produce recombinant glutathione S-transferase-M fusion protein. Various deletion mutant clones, which covered the entire sequence of the M protein, were then generated by inverse PCR and expressed in Escherichia coli to examine, by a Western blot assay, the antigenic reactivity of the clone-derived truncated M proteins with sera from horses either experimentally or naturally infected with EAV. Deletion of the hydrophobic N-terminal 87 aa did not abolish immune reactivity of the protein with serum antibodies to EAV, thereby demonstrating the antigenicity of the C-terminal region (aa 88 to 162) of the M protein. Further truncations of the M-protein C-terminal domain defined particular linear epitope-containing amino acid sequence regions. However, only the M-protein C-terminal region was readily recognized by all EAV-specific horse antisera tested in this study. Based on these findings, only the M-protein C-terminal polypeptide composed of aa 88 to 162 is necessary to identify horse serum antibodies specific to the EAV M protein. Thus, this polypeptide might be useful for serodetection of EAV-infected animals.
马动脉炎病毒(EAV)是一种有包膜的正链RNA病毒,是动脉病毒属的原型。在之前的一篇论文中(A. Kheyar、S. Martin、G. St.-Laurent、P. J. Timoney、W. H. McCollum和D. Archambault,《临床诊断实验室免疫学》4:648 - 652,1997年),我们已经表明,由162个氨基酸(aa)组成的非糖基化膜(M)蛋白是马抗EAV抗体的主要靶点。为了确定M蛋白的抗原区域,将编码EAV M蛋白的cDNA插入原核表达载体pGEX - 4T - 1中,以产生重组谷胱甘肽S - 转移酶 - M融合蛋白。然后通过反向PCR产生覆盖M蛋白整个序列的各种缺失突变体克隆,并在大肠杆菌中表达,通过蛋白质印迹分析来检测克隆衍生的截短M蛋白与实验性或自然感染EAV的马血清的抗原反应性。疏水的N端87个氨基酸的缺失并没有消除该蛋白与抗EAV血清抗体的免疫反应性,从而证明了M蛋白C端区域(第88至162个氨基酸)的抗原性。M蛋白C端结构域的进一步截短确定了特定的含线性表位的氨基酸序列区域。然而,在本研究中测试的所有EAV特异性马抗血清中,只有M蛋白的C端区域易于识别。基于这些发现,只有由第88至162个氨基酸组成的M蛋白C端多肽对于鉴定马血清中针对EAV M蛋白的特异性抗体是必要的。因此,该多肽可能有助于对EAV感染动物进行血清学检测。